Literature DB >> 946509

Pharmacokinetics in clinical practice. 2. Applications.

M Gibaldi, G Levy.   

Abstract

The pharmacokinetic concepts introduced and defined in a preceding article are now applied to the management of drug therapy for the individual patient. The factors that affect the time course of drug concentrations in plasma produced by repetitive administration include the dosing rate, total clearance, biologic half-life, and systemic availability of the drug. A clinical pharmacokinetics service can monitor drug concentrations in biologic fluids, design individualized drug-dosing regimens, and carry out pharmacokinetic diagnostic work-ups to help determine the reasons for a patient's unusual response to drug therapy.

Entities:  

Mesh:

Year:  1976        PMID: 946509

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

1.  Perspectives on the history and scientific contributions of Gerhard Levy.

Authors:  Ho-Leung Fung; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-24       Impact factor: 2.745

2.  Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot study.

Authors:  L M Bezinelli; F P Eduardo; D L C de Carvalho; C E Dos Santos Ferreira; E V de Almeida; L R Sanches; I Esteves; P V Campregher; N Hamerschlak; L Corrêa
Journal:  Bone Marrow Transplant       Date:  2017-07-24       Impact factor: 5.483

Review 3.  The economic potential of dual individualisation methodologies.

Authors:  J A Paladino; G S Zimmer; J J Schentag
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

4.  Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1979-10

5.  Clinical pharmacokinetics: a simplified approach, Part 1.

Authors:  E Perlin; R E Taylor; C Peck
Journal:  J Natl Med Assoc       Date:  1985-06       Impact factor: 1.798

6.  Network pharmacodynamic models for customized cancer therapy.

Authors:  James M Gallo; Marc R Birtwistle
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-04-24

7.  Influence of nutritional status on plasma levels and relative bioavailability of tetracycline.

Authors:  T C Raghuram; K Krishnaswamy
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

8.  Utilising Network Pharmacology to Explore Underlying Mechanism of Astragalus membranaceus in Improving Sepsis-Induced Inflammatory Response by Regulating the Balance of IκBα and NF-κB in Rats.

Authors:  Haiyang Yu; Qihua Ling; Jingwen Cai; Mengzhi Zhang; Huaiquan Liu; Yunzhi Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-31       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.